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Abstract
Background: Cochrane Child Health maintains a register of child-relevant Cochrane systematic reviews (SRs) to
provide a comprehensive source of high-quality evidence. However, a large number of SRs are published outside of
The Cochrane Collaboration (Cochrane), impacting the comprehensiveness of the Cochrane Database of Systematic
Reviews (CDSR). We surveyed authors who published child-relevant SRs with Cochrane and elsewhere in the
medical literature to (1) understand their experiences in preparing and publishing SRs and (2) identify factors
influencing choice of publication venue.
Methods: We identified SRs published in the CDSR for the most recent complete year prior to our study (2013;
n = 145). We searched the medical literature and randomly selected the same number of SRs published the same
year. We developed an internet-based survey and contacted the corresponding author of each review via email.
Data were analyzed descriptively. Qualitative analysis elicited common themes from open-ended questions.
Results: Seventy-six (26 %) responded: 41 % Cochrane, 42 % non-Cochrane, and 17 % published in both venues.
Among respondents who published their SR in both venues (n = 13), 46 % found it easier to publish in a
non-Cochrane journal, 15 % easier with Cochrane, and 31 % similar. Main reasons for conducting SRs with
Cochrane (n = 44) were Cochrane’s positive reputation (82 %) and good impact factor (66 %). Among respondents
who published their SR in a non-Cochrane journal (n = 32), most frequent reasons for not conducting their SR with
Cochrane were time required to follow Cochrane processes (25 %), lack of knowledge about how to conduct an SR
with Cochrane (19 %), administrative processes (16 %), and perception that non-Cochrane journals yielded more
interest (16 %). Among respondents who published their SR in a non-Cochrane journal (n = 32), 78 % did not
register their review and 22 % did not prepare a protocol.
(Continued on next page)
* Correspondence: hartling@ualberta.ca
1Cochrane Child Health, University of Alberta, ECHA 4-472, 11405-87 Avenue,
Edmonton AB T6G 1C9, Canada
2Alberta Research Centre for Health Evidence, University of Alberta, ECHA
4-472, 11405-87 Avenue, Edmonton AB T6G 1C9, Canada
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hartling et al. Systematic Reviews  (2016) 5:104 
DOI 10.1186/s13643-016-0276-7
(Continued from previous page)
Conclusions: Key reasons for publishing in Cochrane are its positive reputation and impact factor. Reasons for
publishing in non-Cochrane sources include lack of familiarity or challenges with the Cochrane processes and desire to
publish in a source more directly relevant to the topic of interest. End users looking for evidence in the form of SRs
need to be aware that there is a vast number of SRs published across the medical literature. Efforts to optimize the
identification of SRs in non-Cochrane sources (e.g., through effective labeling or protocol/review registration) and their
content will help end users find the necessary synthesized evidence to support clinical practice.
Keywords: Systematic reviews, Cochrane Collaboration, Publication, Survey
Background
The Cochrane Collaboration (Cochrane) [http://www.
cochrane.org/] was a pioneer in the area of evidence-
based medicine. Established in 1993, it has been an ad-
vocate for the conduct and dissemination of systematic
reviews of evidence on, initially, healthcare interventions
and, more recently, in the area of diagnostic test accuracy.
Cochrane’s systematic reviews are published in the online
Cochrane Database of Systematic Reviews (CDSR), one of
the databases included in The Cochrane Library [http://
www.cochranelibrary.com/].
Individuals interested in conducting a systematic re-
view through Cochrane are invited to register a title with
one of 52 review groups which each focus on a specific
area of health (e.g., acute respiratory infections, back
and neck, breast cancer, etc.) [1]. Once the title is ap-
proved, review teams comprised of at least two authors
prepare a protocol based on Cochrane guidance [2].
The protocol is submitted to the relevant review group
which manages peer-review and publication of the proto-
col in the CDSR. After approval of the protocol, authors
complete the systematic review; this is also submitted to
the review group which manages peer-review and eventual
publication in the CDSR. Additional details on the process
for proposing and registering new reviews are available
online [3]. The Cochrane Handbook provides detailed
guidance for conducting systematic reviews; [2] further,
Cochrane’s Central Editorial Unit [4] has established stan-
dards for protocols, reviews, and updates of reviews which
are intended to guide the conduct and peer-review of
Cochrane products [5].
Many systematic reviews are also conducted outside of
Cochrane and published as technical reports by sponsor-
ing agencies or in peer-reviewed medical journals. Many
initiatives have emerged to increase the rigor of systematic
reviews and transparency of reporting. One key initiative
is the preferred reporting items for systematic reviews
and meta-analyses (PRISMA) [6]. PRISMA provides a
checklist to help improve reporting by systematic re-
view authors and is endorsed by a number of editorial
organizations and hundreds of journals [7].
In addition to review groups, Cochrane has networks
pertaining to healthcare domains or populations of special
interest [8]. These groups do not oversee the production
of systematic reviews; rather, their functions are to facili-
tate linkages between Cochrane and external stakeholders,
disseminate results of Cochrane reviews to the relevant
stakeholders, and identify and tag titles, protocols, and re-
views relevant to their scope [9]. They may also be in-
volved in promoting the production of reviews, training,
and conducting methodological research related to the
production or dissemination of systematic reviews within
their “field” or population of interest.
Cochrane Child Health is one such entity which was
established to ensure that the unique health needs of
children are reflected within The Cochrane Collabor-
ation [http://www.cochrane.org/], [http://childhealth.co-
chrane.org/]. The Cochrane Library is a key output of
Cochrane and an important source of synthesized evi-
dence to inform healthcare delivery; however, to be most
useful, it needs to include evidence that is up-to-date,
comprehensive, of high methodological quality, and rele-
vant to specific populations such as children. One cru-
cial way of achieving this goal is to encourage authors of
systematic reviews to publish their work in the CDSR. If
authors find it easier and more appealing to publish
their work in non-Cochrane arenas, this will dilute the
comprehensiveness and therefore usefulness and applic-
ability of the CDSR. Furthermore, it will be more diffi-
cult for clinicians and other decision-makers to quickly
find relevant summarized data.
End users looking for evidence in the form of system-
atic reviews need to be aware that there are a vast num-
ber of reviews published outside of Cochrane. Previous
research has shown that Cochrane reviews are of higher
methodological quality; [10] it is also important to iden-
tify whether there are systematic differences in where
authors choose to publish and the rationale for these
choices. As the methods for systematic reviews of
healthcare interventions have become more mainstream,
and increasing numbers of clinicians and researchers
have been trained in these methods and have experience
completing systematic reviews, the facilitation provided
by Cochrane may be less sought after and instead the
processes that occur during review development may be
perceived as a hindrance to timely publication.
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Our goal was to understand the motivations of system-
atic reviewers for conducting and publishing their sys-
tematic reviews either with Cochrane (i.e., in the CDSR)
or in other peer-reviewed journals. To meet our goal, we
conducted a survey of authors who have completed and
published child-relevant systematic reviews with the
Cochrane Collaboration and elsewhere in the medical
literature to (1) understand their experiences in prepar-
ing and publishing reviews and (2) identify factors that
influenced choice of publication venue.
Methods
We created a sample of recently published child-
relevant systematic reviews. We identified all completed
systematic reviews of healthcare interventions published
in the CDSR for the most recent complete year prior to
our study (2013; n = 145). We felt that capturing reviews
published during a complete year would provide a broad
representation to identify variables of interest. We
then searched the medical literature (Additional file 1:
Appendix A) and randomly selected the same number of
child-relevant systematic reviews focusing on healthcare
interventions published in the same year. We first
identified 4855 records of systematic reviews from the
same year. We defined a systematic review as all of
the following (Additional file 1: Appendix B): (a) included
a literature search that contained more than one named
database, or one named database plus another sources
(e.g., checking references, handsearching, contact with re-
searchers to identify published studies, citation searching,
internet searching, or other systematic attempts to identify
potential studies); (b) reported inclusion and/or exclusion
criteria; (c) described methods for study selection and data
extraction; (d) assessed methodological quality of included
studies; and (e) described or summarized results of the in-
cluded/relevant studies. Non English-language reviews
were excluded.
The list of systematic review records was randomly or-
dered, and we screened citations until we found an
equivalent number of systematic reviews (n = 145) meet-
ing our eligibility criteria, i.e., therapeutic intervention,
child-relevant (Additional file 1: Appendix B). We de-
fined a child-relevant therapeutic intervention as either
of the following: (a) an intervention intended to improve
the health and well-being of children; and (b) studies on
breastfeeding or nutritional supplements for fetal and/or
newborn health. Studies without pediatric outcomes
were excluded, as well as primarily descriptive reports of
studies in a given field with no synthesis of results (e.g.,
a descriptive analysis characterizing RCTs conducted in
child health). We defined child-relevant as (a) intended
to include children 0 to 18 years; (b) contained adults
and children; or (c) studied an intervention/condition
intended to improve health and well-being of children.
Systematic reviews that only examined or reported ma-
ternal outcomes were excluded. We then identified the
corresponding author of each review. We ensured that
none of the authors surveyed were duplicates within and
between lists (Cochrane vs. non-Cochrane). Since our
non-Cochrane list was generated by screening records
until we identified our target number, some of the
Cochrane reviews may have also been published in a
non-Cochrane source.
We developed an internet-based survey using Re-
search Electronic Data Capture (REDCap) software [11]
(Additional file 1: Appendix C). Study data were collected
and managed using REDCap electronic data capture tools
hosted at the University of Alberta [11]. REDCap is a
secure, web-based application designed to support data
capture for research studies, providing (1) an intuitive
interface for validated data entry; (2) audit trails for track-
ing data manipulation and export procedures; (3) auto-
mated export procedures for seamless data downloads to
common statistical packages; and (4) procedures for
importing data from external sources [12].
Survey questions asked about: (1) why authors chose
to publish their systematic reviews within or outside of
the Cochrane Collaboration; (2) authors’ experiences
preparing their systematic review; (3) whether they
would undertake another review either within or outside
of Cochrane; and (4) the reasoning and experiences of
authors who chose to publish the same review in the
CDSR and also in another journal. For most questions,
we had pre-defined options that respondents could se-
lect as well as an “other” option with an opportunity for
the respondent to elaborate with text descriptions. Prior
to implementation, the survey was pilot tested among a
convenience sample of five review authors (one was a co-
author, RF, and four were independent of the study team)
to ensure that the questions were worded appropriately
and information was presented in a way that would elicit
appropriate responses. The survey was revised based on
their responses and feedback. Among the five individuals
who pilot-tested the survey, three authors had published
in both Cochrane and non-Cochrane sources, while two
authors had published only in non-Cochrane sources.
We contacted the corresponding author of each review
via email using the author’s published contact information.
Participants were asked to respond to questions with re-
spect to the specific publications (SR) we had identified.
We identified 290 authors: 145 Cochrane authors and 145
non-Cochrane authors. We sent 290 emails with links to
the survey directly to corresponding authors of the identi-
fied reviews. The survey was administered for 6 weeks,
from April to May 2015. We sent two reminders following
the initial email, each at 2-week intervals.
The study was approved by the University of Alberta’s
research ethics board prior to implementation. All survey
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responses were anonymized. At the end of the survey, par-
ticipants had the opportunity to enter their name in a
draw for one of six US$50 Amazon gift cards (the names
were entered on a separate web page and were not linked
to the survey). We indicated that they would have about a
1 in 50 chance of winning based on our complete study
sample; based on actual participation, the chance of win-
ning was 1 in 13. Only one survey question was
mandatory (i.e., respondents were required to complete
the question before continuing with the survey); this was
the first question asking authors to indicate if they had
published with Cochrane, non-Cochrane or both. The
remaining questions were based on response to this first
question with slightly different questions asked of each
group (Additional file 1: Appendix C). No other questions
were mandatory in order to submit the survey. For incom-
plete questionnaires, we used the data for the questions
that were answered; incomplete questions were marked as
missing data. Respondents were able to amend answers at
any time prior to submission of the survey (i.e., they could
go backwards and forwards through the survey as they
liked until they submitted). The survey invitation was
linked to each participant’s email address. Participants
were able to open the survey using the link as many times
as they liked until they submitted the survey, at which
time the link no longer worked. This ensured that we did
not obtain repeat or duplicate responses.
Data were analyzed descriptively with univariate statis-
tics using SPSS version 22.0. We divided respondents into
three categories: (1) those who had only published their
systematic review in the CDSR; (2) those who had pub-
lished their review in both the CDSR and a non-Cochrane
source (based on information provided by respondents);
and (3) those who had only published their review in a
non-Cochrane source. Qualitative analysis of the re-
sponses to open-ended survey questions was conducted to
elicit common themes.
Results
Seventy-six (26 %) individuals responded. Table 1 pre-
sents characteristics of the respondents; 41 % (n = 31)
had published their review with Cochrane, 42 % (n = 32)
in a non-Cochrane source, and 17 % (n = 13) in both.
The majority of respondents were researchers (45 %;
n = 34), clinician-scientists (32 %; n = 24), or clinicians
(13 %; n = 10). A majority of participants had completed
multiple systematic reviews (2–5, 41 % (n = 31); 6–10,
13 % (n = 10); 11–20, 5 % (n = 4); >20, 13 % (n = 10)), with
24 % (n = 18) of respondents having completed only one
systematic review. A minority of the sample had no
current involvement with Cochrane (38 %; n = 29); the
proportion was higher for the authors who had only pub-
lished their systematic review in a non-Cochrane source
(75 %; n = 24).
Among respondents who published their systematic
review in both Cochrane and non-Cochrane journals
(n = 13), the majority published in Cochrane first
(77 %; n = 10). Nearly half reported it was easier to
publish their systematic review in a non-Cochrane
journal (46 %; n = 6); only 15 % (n = 2) found it easier
with Cochrane, and 31 % (n = 4) rated ease of pub-
lishing equal between Cochrane and non-Cochrane
journals. Respondents were divided in their rating of
the timeliness of publishing with 31 % (n = 4) indicat-
ing it was more timely with Cochrane, 31 % (n = 4)
more timely with a non-Cochrane journal, and 39 %
(n = 5) indicating the same. A minority (31 %; n = 4) paid
fees to publish their article in a peer-reviewed journal, and
a similar proportion (31 %; n = 4) published in an
open access journal.
Among respondents who published their systematic
review in Cochrane (n = 44), the main reasons for con-
ducting their systematic reviews with Cochrane were
Cochrane’s positive reputation (82 %; n = 36) and good
impact factor (66 %; n = 29) (respondents could select
multiple response options). The majority who published
their review with Cochrane were satisfied (48 %; n = 21)
or very satisfied (32 %; n = 14). Respondents also rated
the specific support they received (Fig. 1).
Table 2 summarizes responses of authors who pub-
lished their systematic review in a non-Cochrane journal
(n = 32). Nineteen percent (n = 6) had considered con-
ducting their SR with Cochrane, while 75 % (n = 24) had
not. The most frequent reasons for not conducting their
systematic review with Cochrane were time required to
follow Cochrane processes (25 %; n = 8), lack of know-
ledge about how to conduct a systematic review with
Cochrane (19 %; n = 6), administrative processes (16 %;
n = 5), and a perception that peer-reviewed journal pub-
lication yielded more interest (16 %; n = 5). Seventy-eight
percent (n = 25) did not register their review and 22 %
(n = 7) did not prepare a protocol before starting the sys-
tematic review. The most common reasons for not regis-
tering their systematic review were lack of knowledge
about systematic review registers (31 %; n = 10), they did
not think of it (19 %; n = 6), and not interested due to
time required (13 %; n = 4). Respondents who published
their systematic review in a non-Cochrane journal used
the following Cochrane resources: Cochrane Library
(50 %; n = 16), Cochrane Handbook for Systematic Re-
viewers of Interventions (50 %; n = 16), and a trials regis-
ter (13 %; n = 4).
Overall, the majority (92 %; n = 70) of respondents in-
dicated they would participate as an author in another
systematic review. Overall, the majority (72 %; n = 52) in-
dicated they would participate with Cochrane, with 20 %
(n = 15) indicating outside of Cochrane. Among those
not interested in participating with Cochrane (n = 15),
Hartling et al. Systematic Reviews  (2016) 5:104 Page 4 of 13
the majority indicated that they were not interested due
to the administrative processes (53 %; n = 8) or the time
required to follow Cochrane processes (47 %; n = 7).
Themes that emerged from the open-ended responses,
with supporting statements, are provided in Table 3. The
following were some of the positive themes identified
regarding The Cochrane Collaboration: Cochrane is
recognized as producing high-quality, methodologically
rigorous systematic reviews; Cochrane is considered an
excellent organization with which to work; the support in
producing systematic reviews offered through Cochrane is
highly valued; and the resources offered through Cochrane
are highly valued (e.g., RevMan, Handbook). The follow-
ing were some criticisms of Cochrane processes for review
production: application of systematic review standards
varies by Cochrane Review Group; producing a Cochrane
review is lengthy; some of the Cochrane requirements
(e.g., search completed within 12 months) conflict with
process (e.g., time for editorial review); time requirements
often prohibit trainees (e.g., graduate students) from work-
ing with Cochrane; the increasing methodological require-
ments (e.g., GRADE) are adding complexity for authors,














Clinician 10 (13.2) 4 (12.9) 3 (23.1) 3 (9.4)
Clinician-scientist 24 (31.6) 9 (29.0) 2 (15.4) 13 (40.6)
Researcher 34 (44.7) 14 (45.2) 8 (61.5) 12 (37.5)
Other 5 (6.6) 2 (6.5) 0 (0) 3 (9.4)
No response 3 (3.9) 2 (6.5) 0 (0) 1 (3.1)
Number of systematic reviews published as a lead or co-author
1 18 (23.7) 7 (22.6) 2 (15.4) 9 (28.1)
2–5 31 (40.8) 12 (38.7) 4 (30.8) 15 (46.9)
6–10 10 (13.2) 5 (16.1) 3 (23.1) 2 (6.3)
11–20 4 (5.3) 2 (6.5) 1 (7.7) 1 (3.1)
>20 10 (13.2) 3 (9.7) 3 (23.1) 4 (12.5)
No response 3 (3.9) 2 (6.5) 0 (0) 1 (3.1)
Current involvement with The Cochrane Collaborationa
Yes—author on current review (updating as required) 30 (39.5) 21 (67.7) 6 (46.2) 3 (9.4)
Yes—author on another review 33 (43.4) 21 (67.7) 8 (61.5) 4 (12.5)
Yes—employee of a Cochrane entity 6 (7.9) 5 (16.1) 0 (0) 1 (3.1)
Yes—other 7 (9.2) 4 (12.9) 2 (15.4) 1 (3.1)
No involvement 29 (38.2) 2 (6.5) 3 (23.1) 24 (75)
Would you participate as an author in another systematic review
No 2 (2.6) 0 (0) 0 (0) 2 (6.3)
Yes—with Cochrane 55 (72.3) 28 (86.4) 10 (76.9) 17 (53.1)
Yes—outside Cochrane 15 (19.7) 1 (3.2) 3 (23.1) 11 (34.4)
No response 4 (5.3) 2 (6.5) 0 (0) 2 (6.3)
Reasons for not registering and publishing a future systematic review
with The Cochrane Collaborationa
Not interested due to administrative processes 8 (10.5) 0 (0) 1 (7.7) 7 (21.9)
Not interested due to reputation of Cochrane 0 (0) 0 (0) 0 (0) 0 (0)
Not interested due to time required to follow Cochrane’s processes 7 (9.2) 0 (0) 2 (15.4) 5 (15.6)
Not interested as peer-reviewed journal has higher impact factor 2 (2.6) 0 (0) 0 (0) 2 (6.3)
Source other than Cochrane yields more academic credit 0 (0) 0 (0) 0 (0) 0 (0)
Other 6 (7.9) 1 (3.2) 1 (7.7) 4 (12.5)
aMore than one response permitted for this item
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require additional training, and increase production time.
Related to the last theme was an impression that the in-
creasing methodological requirements may have an ad-
verse impact on the readability and utility of the systematic
reviews. Finally, the following themes help explain authors’
choice to seek publication outside of Cochrane: publication
in non-Cochrane sources may reach a wider audience, or
specific audience of interest (e.g., clinical specialty), and the
scope of Cochrane is restrictive (e.g., only RCTs, clinical
topics of interest, quantitative focus).
Suggestions offered by respondents to increase involve-
ment and production of systematic reviews with Cochrane
are summarized in Table 4. These include: streamlining
processes; continuing to offer training and support; empha-
sizing the high-quality systematic reviews offered through
Cochrane; increasing awareness about the high-impact fac-
tor of the CDSR; and addressing concerns of Cochrane be-
ing overly restrictive and quantitatively focused.
Discussion
Our results provide some insights into authors’ experiences
preparing and publishing systematic reviews, as well as fac-
tors that influence choice of publication arena, specifically
Cochrane and non-Cochrane sources. Key reasons for pub-
lishing in Cochrane are its positive reputation and impact
factor. Reasons for publishing in non-Cochrane sources in-
clude lack of familiarity or challenges with the Cochrane
processes, and desire to publish in a source more directly
relevant to the topic of interest. End users looking for
evidence in the form of systematic reviews need to be
aware that there are a vast number of systematic re-
views published across the medical literature. The value of
publishing systematic reviews in a single source (e.g.,
Cochrane) is that they are readily identifiable by end users.
Efforts to optimize the identification of systematic reviews
in non-Cochrane sources (e.g., through effective labeling
or protocol/review registration) and their content will help
end users find the necessary synthesized evidence to sup-
port clinical practice.
Cochrane was established over 20 years ago and its
impact on the production of systematic reviews and
development of systematic review methods is highly
evident in the results of this survey. Even authors
who did not conduct and publish their systematic reviews
with Cochrane used Cochrane resources. The Cochrane
Handbook for Systematic Reviews of Interventions is pub-
lished and available online and widely used [2]. Our survey
found that authors value the support offered through
Cochrane in producing reviews, and the technical re-
sources and guidance available.
Previous research comparing Cochrane and non-
Cochrane reviews has found that Cochrane reviews are of
superior methodological quality [10]. Cochrane processes
(e.g., title registration, peer-review, and publication of pro-
tocols) were intended to increase transparency, reduce du-
plication, and optimize methodological rigor; however,
there is little empiric evidence of the impact of the contri-
butions of specific processes on the quality and uptake of
Cochrane reviews. Moreover, the process of peer-review
can be lengthy, resource intensive, and there is little
evidence of its effectiveness in ensuring the quality of
published research [13].
While considered more methodologically rigorous, it
is unknown whether Cochrane reviews are perceived to
Fig. 1 Respondents’ rating of support they received through the Cochrane Collaboration
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Table 2 Responses of authors who published in non-Cochrane journal (n = 32)
Considered registering title and conducting their SR with Cochrane N (%)
Yes 6 (18.8)
No 24 (75)
No response 2 (6.3)
Reasons for not conducting SR with Cochranea
Did not know about Cochrane 1 (3.1)
Did not know how to conduct a systematic review with Cochrane 6 (18.8)
Administrative processes 5 (15.6)
Reputation of Cochrane 1 (3.1)
Time required to follow Cochrane processes 8 (25)
Peer-reviewed journal publication yields more interest 5 (15.6)
Wanted to reach a different audience 4 (12.5)
Procedures for publication more streamlined with peer-reviewed journal 4 (12.5)
Peer-reviewed journal has higher impact factor 1 (3.1)
Published work likely to be cited more outside of Cochrane 2 (6.3)
Source other than Cochrane yields more academic credit 1 (3.1)
Did not think of it 4 (12.5)
Other 4 (12.5)
Registered review with a SR register such as PROSPERO
Yes 5 (15.6)
No 25 (78.1)
No response 2 (6.3)
Reasons for not registering review with a SR registera
Did not know about SR registers 10 (31.3)
Did not know how to register a SR with a register 0 (0)
Not interested due to administrative processes 2 (6.3)
Not interested due to time required 4 (12.5)
Did not think of it 6 (18.8)
Other 5 (15.6)
Prepared protocol before starting SR
Yes 24 (75)
No 7 (21.9)
No response 1 (3.1)
Published SR protocol in peer-reviewed journal
Yes 4 (12.5)
No 20 (62.583.3)
No response 8 (25)




Reasons for not publishing SR protocol in a peer-reviewed journala
Did not know about publication of SR protocols 6 (18.8)
Did not know how to publish a SR protocol 0 (0)
Not interested due to administrative processes 2 (6.3)
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Table 2 Responses of authors who published in non-Cochrane journal (n = 32) (Continued)
Not interested due to time required 7 (21.9)
Did not see the value in publishing the protocol 4 (12.5)
Did not think of it 4 (12.5)
Other 3 (9.4)
Accessed specialized support of a librarian and/or information specialist
Yes 21 (65.6)
No 10 (31.3)
No response 1 (3.1)
Accessed specialized support of a statistician
Yes 13 (40.6)
No 18 (56.3)
No response 1 (3.1)








Paid publication fees to publish SR in a peer-reviewed journal
Yes 6 (18.8)
No 25 (78.1)
No response 1 (3.1)
Published SR in an open access journal
Yes 9 (28.1)
No 22 (68.8)
No response 1 (3.1)
Aware of Cochrane SRs
Yes 29 (90.6)
No 2 (6.3)
No response 1 (3.1)
Used Cochrane resources in preparing SR
Yes 22 (68.8)
No 8 (25)
I did not know Cochrane had these resources 1 (3.1)
No response 1 (3.1)
Cochrane resources used in preparing SR
The Cochrane Library 16 (50)
The Cochrane Handbook for Systematic Reviewers of Interventions 16 (50)
A Trials Register 4 (12.5)
Assistance from Cochrane staff 0 (0)
Other 4 (12.5)
N/A not applicable, SR systematic review
aMore than one response permitted for this item
Hartling et al. Systematic Reviews  (2016) 5:104 Page 8 of 13
Table 3 Themes and supporting statements from open-ended questions
Theme Sample supporting statements from survey respondents
Cochrane is recognized as producing high-quality, methodologically
rigorous systematic reviews.
“It can be a very long process, but the rigour of the reviews is ensured
through much of this.”
“I love the structured nature of the review and the way that all the questions
you have a clearly answered within the handbook.”
“Once completed, very happy. But the process was very long. However, this
was for fine tuning and ensuring high quality, so justifiable in the end.”
“The support and enthusiasm for high quality reviews is excellent. Best
evidence reviews endorsed by Cochrane and reputable journals are
fundamental to clinical decision-making.”
“In the forefront of methodological development.”
Cochrane is considered an excellent organization with which to work. “Fantastic. An excellent organisation to work with.”
“All very professional and I always received responses in a timely manner.”
“…my best colleagues and the people I respect more professionally are in the
Cochrane Collaboration. I think that is much more than an editorial group, it
is rather an approach to health care.”
“I think the Cochrane collaboration is a great organisation. I think it is great
that anybody can get involved in writing Cochrane reviews…”
The support in producing systematic reviews offered through Cochrane
is highly valued.
“The access provided to an specialist to help develop the search and to run
the searches is invaluable in the preparation of reviews.”
“They were extremely patient, helpful, provide adequate and timely guidance
for the statistical analysis and ensured the review's completion.”
“They were very supportive throughout the process.”
“The support given by the group was brilliant throughout.”
“A very enjoyable and rewarding process. All the review writing software and
other resources are easy to access and use.”
“Far more editorial support than ordinary journals would give.”
The process is standardized but application of standards varies by review
group.
“The process is standardised, though quality and quantity of the process is
very different by each review group.”
“I think that the process involved in getting these reviews done can be
improved and streamlined across the review groups.”
The process of producing a Cochrane systematic review is lengthy. “Good support. Total procedure was far too long.”
“It took longer than I had initially anticipated.”
“There is a long gap of time between finishing protocol and the first
submission for review? This causes loss of momentum. This should be cut
short and an intermediate stage of filling in the data should be introduced. A
tutorial on analysis After data collection will be useful and decrease the
dependence on the Cochrane expert author.”
“Submitting a title and wait to hear if it is accepted. Submitting a protocol
and the lengthy process that follow for it to be published. The lengthy peer
review process of the review itself. I think that that submission from a third
World country is not treated fairly.”
“Takes more time than a traditional journal.”
“The review process and clearing the protocol thought the specialty sub-
groups is long and dampens momentum on projects. The ongoing commit-
ment to review and update emerging evidence after the completion of the re-
view is also daunting.”
Some Cochrane requirements (e.g., search completed within 12 months)
conflict with process (e.g., time for editorial review).
“Peer review and iterations of the protocol and review added an unacceptable
time lag to completing the review. The requirement for searches to be done
within 6-12 months of publication of the review conflicts with the time in-
volved in the editorial processes and peer review of the final review.”
Time requirements often prohibit trainees (e.g., graduate students) from
working with Cochrane.
“Excellent support, but too long procedure to be included in regular PhD
trajectories.”
“Most of the SRs I have published over the years start as graduate student
projects to understand what is available around the topic of their thesis.
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be more accessible and usable, and whether there is a
difference in terms of uptake and use of Cochrane vs.
non-Cochrane reviews in clinical practice. Furthermore,
respondents indicated that they published in non-
Cochrane sources to reach a different target audience, in
particular, members of their clinical specialty. Further re-
search about publication venue for systematic reviews
and where end users look for reviews may help ensure
the Cochrane Library (and CDSR) is recognized as a
“go-to” source for the most relevant and high-quality
evidence.
Almost a quarter of non-Cochrane authors indicated
that they did not prepare a protocol prior to conducting
their review; this is consistent with earlier reports [10].
To our knowledge, there is no evidence that has linked
lower methodological quality of systematic reviews with-
out an a priori protocol (i.e., detailed methods beyond
simply registering in a systematic reviews register such
as PROSPERO). While some non-Cochrane respondents
identified the administrative processes as a deterrent to
publishing in the CDSR, there is currently a lack of evi-
dence demonstrating that Cochrane reviews actually take
longer to produce.
Our findings suggest a tension resulting from the mo-
tivation to produce high-quality systematic reviews and
the administrative processes, perceived time, and meth-
odological standards required to achieve this goal. Re-
spondents provided some suggestions to address this
challenge. Current investigations and interest in tech-
nologies and methods to increase efficiencies may help
address some of the identified challenges. There is a
growing interest as well as work being done within
Cochrane to investigate technological approaches to
streamlining review production, such as text mining
and machine learning [14–17]. Covidence, a new soft-
ware package for review production that links with
RevMan and GRADEPro, has also been developed to
manage all stages of review production and is revised
regularly based on end user input [18]. The EMBASE
project has investigated the use of crowdsourcing to
Table 3 Themes and supporting statements from open-ended questions (Continued)
When we finally decide to pursue publication it just does not make sense to
start a Cochrane process.”
The increasing methodological requirements (e.g., GRADE) are adding
complexity for authors, require additional training, and increase
production time.
“There should be a standard checklist for things to do especially with regards
to use of GRADE criteria. Authors should be helped with this relatively new
concept and be offered more help and encouragement.”
“My only caveat is that it is hard at times to get every detail of the process
exactly as the Cochrane editor wishes (though I understand the benefits as
well as the disadvantages of a formulaic approach)”
“Difficult as the rules and regulations are much more onerous I would
probably advise people to now avoid the Cochrane process. MECIR guidelines
are being interpreted by review groups in different ways and are putting the
onus on authors to check about compliance to all the guidelines”
“My experience is that people [are] in general scared by the amount of work
needed.”
The increasing methodological requirements may have an adverse
impact on the readability and utility of the systematic reviews.
“I think that the ever increasing requirements e.g., MECIR, summary of
findings tables etc. is making the process for reviewers even more difficult and
is having an adverse impact on the readability of the reviews.”
Publication in non-Cochrane sources may reach a wider audience, or
specific audience of interest (e.g., clinical specialty).
“To increase coverage and readership”
“To give wide audience to a topic we consider extremely important.”
“It was an important clinical question and we used advanced methods which
we thought would be of interest to journals”
“We think CDSR is limited in some countries so publishing in paper journal
may produce more impact to public and health care.”
“More publications for the same work”
The scope of Cochrane is restrictive (e.g., only randomized controlled
trials, clinical topics of interest, quantitative focus).
“Cochrane…very strict on what it accepts. They are also more [topics] which
can fall outside the Cochrane remit”
“We believe that SRs are justified even when no RCTs are available. Clinicians
need to make decisions based on the best available evidence even if it not
RCT driven. The Cochrane SRs do have as condition to include only RCTs.”
“I think that The Cochrane Collaboration is often associated with very strict
rules and regulations”
“I dislike working with Cochrane because they are so slow and believe their
way is the only/right way, even when there are alternative perspectives.”
CDSR Cochrane Database of Systematic Reviews, RCTs randomized controlled trials, SRs systematic reviews
Hartling et al. Systematic Reviews  (2016) 5:104 Page 10 of 13
increase efficiencies in screening records for CENTRAL
[19–22]; similar approaches could be investigated
within the production of reviews.
The timing of this study coincides with a widespread
internal review of the structure and function of Cochrane’s
component groups, including the review groups, methods
groups, fields, and the consumer network. One of the
key motivations for this internal review is to ensure
that Cochrane continues to meet its mandate of produ-
cing high-quality, relevant, accessible evidence to inform
healthcare decision-making. Our results may provide
useful information as Cochrane continues to achieve its
mandate [23].
This study is limited by the response rate which may
affect generalizability; further, the invitation sent to par-
ticipants had the name and title of one of the Directors
of Cochrane Child Health which could have influenced
response rate, who responded, and the nature of re-
sponses. A further concern is that some of the questions
may not have been phrased in a balanced way which
could have affected the responses we received, i.e., they
may be perceived to be stated from a Cochrane perspec-
tive. For example, Cochrane authors were asked why
they published with Cochrane, while non-Cochrane au-
thors were not asked the equivalent question, i.e., they
were asked why they did not publish in Cochrane, not
why they published in a given journal. However, there
was a similar number of respondents who had published
in Cochrane and non-Cochrane sources, and thematic
analyses indicated varied views with both positive and
negative opinions. It is important to interpret the results
in light of our desire to have a single “go-to” source for
high-quality evidence in child health, or at a minimum
that reviews of relevance are readily identifiable.
A further limitation is that the sample was derived
from child-relevant systematic reviews published in a
single year (2013) which may also limit generalizability.
Opinions may vary for authors who were updating their
reviews compared with authors who were conducting new
reviews; however, we did not have adequate information
Table 4 Suggestions offered by respondents to increase involvement and production of systematic reviews with the Cochrane
Collaboration
Theme Sample supporting statements from survey respondents
Streamline processes. “…reducing the time involved in preparing and publishing with Cochrane”
“Need to simplify the process and stop imposing new guidelines which add further
complexity and make reviews less accessible to readers.”
“Promoting rapid review methodology, exploring the use of crowd sourcing for
supporting screening of citations, quicker turnaround time from submission of protocol/
review manuscript to publication”
Continue to offer training and support. “Continue to offer the workshops on a frequent basis.”
“The training you can attend is invaluable and I have used these skills in a lot of places.”
“We need more training and dissemination of the Cochrane work among clinicians and
researchers.”
“Get medical students involved.”
Emphasize the high quality of systematic reviews offered
through The Cochrane Collaboration.
“It is a big challenge. I no longer view Cochrane as the gold standard. I believe Cochrane
has set the standard but it is definitely possible to conduct a review which is as good as
a Cochrane review and publish it much more rapidly outside of Cochrane. Personally I
would always choose to do a Cochrane review from a loyalty perspective, the impact
factor and the fact that I believe Cochrane peer referees and editors always consistently
ensure a quality product.”
Increase awareness about the high impact factor of the
Cochrane Database of Systematic Reviews (CDSR).
“Impact factor is not well-known.”
“…change the impression that somehow a journal submission is ‘better’. My impression is
that Cochrane reviews are often of higher quality on average than reviews published in
journals. Yet, I would probably still choose a journal as a home for my reviews because
journal publication often counts more toward tenure evaluation (or some other
evaluation process). I’m not sure if Cochrane publication has the same weight.”
Identify topics for review. “Review groups should develop priority lists for reviews if they already do not have such
lists.”
Address concerns of Cochrane being overly restrictive and
quantitatively focused.
“…greater emphasis on reviews other than effectiveness of interventions”
“I think that Cochrane is seen as the gold standard in SRs which is wonderful for the
collaboration. However, this may make it seem less attainable and less relatable to many
groups and individuals. Attempting to still stress the high quality of reviews, while
somewhat changing the very strict and quantitative based reputation can increase
authorship and readership.”
SRs systematic review
Hartling et al. Systematic Reviews  (2016) 5:104 Page 11 of 13
to assess or comment on these differences. Finally, opin-
ions and motives may vary by clinical topic (even within
child health) and our selection of non-Cochrane reviews
may not have matched the same topics covered in our
sample of Cochrane reviews.
Conclusions
We identified reasons that authors publish systematic re-
views in Cochrane and non-Cochrane sources. These in-
clude the reputation of Cochrane, familiarity or challenges
with Cochrane processes, and relevance of the publication
venue to the topic of interest. The identification of
Cochrane systematic reviews is easier because they reside
in the same place (i.e., CDSR housed in The Cochrane Li-
brary). Efforts to optimize the identification of systematic
reviews in non-Cochrane sources (e.g., through effective
labeling or protocol/review registration) and their content
will help end users find the necessary synthesized evidence
to support clinical practice.
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